Tim Scott, JD
Tim is the co-founder and CEO of TEGA Therapeutics, Inc. He previously was founder and President of Pharmatek Laboratories, a contract development and manufacturing company which he sold to Catalent Pharma Solutions in 2016. Tim serves on the Board of Avelas, a bioscience company working to create better outcomes for cancer patients with its activatable cell-penetrating peptide technology. He also is a member of the boards of BIOCOM, a non-profit organization supporting the needs of bio/pharma companies California and CONNECT, a non-profit helping to create and scale innovation companies in San Diego. In the community, Tim serves as a trustee for the La Jolla Playhouse, a Tony-award winning regional theatre in La Jolla, California. He earned his B.A. in Biochemistry from the University of California, San Diego. He earned his J.D. from the University of San Diego and is a member of the California Bar.